InsiderInsights Daily Ratings Report: February 4, 2021
InsiderInsights Ratings of Companies with Open-Market Form 4 Purchases; Sales Filed at the SEC on the date above. We separate the real investment intelligence from the noise. Saving you time, and improving your research process
Evelo Biosciences is discovering and developing therapies designed to engage immune cells in the small intestine to drive therapeutic immune effects throughout the body for the treatment of inflammatory diseases and cancers. The company is developing monoclonal microbials, a modality of oral biologic medicines. The company initiates a clinical trial of its monoclonal microbial candidate in inflammatory diseases, EDP1066 and initiates a clinical trial for its inflammation candidate, EDP1815. The company is developing monoclonal microbial therapies in oncology. The company initiates its clinical trial of its oncology product candidate, EDP1503 in combination with KEYTRUDA? (pembrolizumab) in various oncology indications.
FVCBankcorp is a bank holding company. Through its subsidiary, FVCbank, the company operates as a community oriented and managed commercial bank. The company provides a variety of lending products, including commercial real estate loans, commercial construction loans, commercial loans, SBA lending, asset based lending and accounts receivable financing, home equity loans, and consumer loans. The company also provides an array of deposit products, including interest and noninterest-bearing transaction accounts, certificates of deposit and money market accounts. Through third party networks, the company provides its customers access to a range of business insurance products and business and consumer credit card products.
Yield10 Bioscience is an agricultural bioscience company focusing on the development of technologies to enable step-change increases in crop yield. The company is developing several yield gene traits in its pipeline in canola, soybean and corn.
Insiderinsights' advanced insider analytics combine statistical track records with numerous behavioral metrics to rate the significance of a firm's insider trading history in real time.
Academic studies and the experience of professionals back the common sense conclusion that the Form 4 data filed daily at the SEC is a profitable data stream to mine for investment intelligence. But most investors use commodity insider feeds that are full of noise and time-consuming to analyze, or ratings services that employ last century's simplistic insider scoring methodology.
InsiderInsights compiles Daily, Weekly, and Monthly reports that list US equities with recent insider activity, along with proprietary Company Ratings clearly indicating the Significance Level of insider sentiment. Our monthly Special Screens further combine our Ratings with various fundamental and price action criteria, to highlight the best value, growth, momentum, and short ideas coming from the executive suite.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.